about
Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania InfectionThe immunology of post-kala-azar dermal leishmaniasis (PKDL)Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterolIn vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisImmunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease.Evaluation of the Leishmanicidal Activity of Rutaceae and Lauraceae Ethanol Extracts on Golden Syrian Hamster (Mesocricetus auratus) Peritoneal Macrophages.The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.The role of inflammatory, anti-inflammatory, and regulatory cytokines in patients infected with cutaneous leishmaniasis in Amazonas State, Brazil.Dual immune modulatory effect of vitamin A in human visceral leishmaniasis.Deception and manipulation: the arms of leishmania, a successful parasiteInterferon-gamma and interlukin-4 patterns in BALB/c mice suffering from cutaneous leishmaniasis treated with cantharidin.Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.Development of Vaccines against Visceral LeishmaniasisImmunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineKaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1β/cNOS/NO PathwayTranscription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production.Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).Development of Leishmania vaccines: predicting the future from past and present experience.Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.Toll-like receptors in leishmania infections: guardians or promoters?Therapeutic vaccines for leishmaniasis.Implications of co-infection of Leptomonas in visceral leishmaniasis in India.Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major.Solute carrier protein family 11 member 1 (Slc11a1) activation efficiently inhibits Leishmania donovani survival in host macrophages.Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity.The role of chemokines and their receptors during protist parasite infections.Seco-limonoid derived from Raputia heptaphylla promotes the control of cutaneous leishmaniasis in hamsters (Mesocricetus auratus).Immunohistochemical evidence of stress and inflammatory markers in mouse models of cutaneous leishmaniosis.Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.Sir2-Related Protein 1 from Leishmania amazonensis is a glycosylated NAD+-dependent deacetylase.The influence of low oxygen on macrophage response to Leishmania infection.Increased Th17 functions are accompanied by Tregs activities in lupoid leishmaniasis.Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis.T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.Long-term cell culture isolated from lesions of mice infected with Leishmania amazonensis: a new approach to study mononuclear phagocyte subpopulations during the infection.
P2860
Q21284970-A8192F64-7DFE-4E30-8450-F44891756D1DQ26739701-3324F8E4-3540-4FCF-9C95-DD3EEBB62320Q28542482-724BA9B2-5A1A-457C-A0FB-940ED7F8E6F4Q33559668-59620C56-6619-4F08-887A-3551F6B80FC0Q33749424-BD23C717-303F-43D4-BB24-72BDF620189BQ33877775-253DBCD2-D506-418B-9F93-1C0935B6933FQ34219774-3CF10140-B1CF-48A7-8FD2-4D57F5BF459EQ34257064-24531940-643B-4356-86FF-03B050BDDFDEQ34275996-C0288E94-E875-4BE9-AEE4-D0ABC421EBDEQ34369161-EA2D817D-29EC-4B19-A81D-BBF6FA7F6741Q34443494-31023F33-8126-462E-9511-2581882BC3F0Q35058597-D5F46CF7-3231-4F9D-A58C-B95A9A3E33A2Q35115431-406C9CA1-21DE-4698-AD5E-7544F4F7FF0FQ35198753-4059D497-4ACE-4518-A5E0-A03E6F8F2540Q35207606-3C52DB5D-9CD3-4A2B-8DF3-D045E5212199Q35326248-9E784063-FB5F-4E95-AAC0-09238DF6640DQ35649691-5A9FF631-60A3-4075-AD5A-CB42231615F5Q35806436-F9DB60B7-E59C-42E6-BE0D-7E91C30588CAQ35895008-4B1BA622-3375-4300-B3B2-70C1B8CCDD94Q36680084-572C5E7D-2516-4259-8961-157772912C54Q36700453-312749C0-7371-4836-8B04-0245EFF0FFF5Q37239554-2F06433E-91F9-4370-8B5F-81230D8A1141Q38004493-F07C6D79-7E8A-49BF-8F70-B85AD5979041Q38235456-FB38EDED-8A8B-4A75-A0C0-FBD3425A12CAQ38613966-F3FA281F-8892-46B2-9BB8-762C5CA23DC7Q40038032-8FD70276-83EE-4B1D-A9A9-F4D583B02BF2Q40076960-3F0D16EB-ED07-4AA3-8FB2-FF795F8C9901Q40164401-7F46D9B1-324E-42D7-B1E2-5C02B372328FQ40329762-6656EBC9-91AD-4DE4-97CB-D4F50C438A1FQ40515876-A39E3609-3F65-467B-A1D2-9C763C6CBD21Q40861083-EFDBB5F0-2EFD-45E4-8D2C-068FF5E7D2E9Q41302861-D41D2E60-3432-4652-899D-1C7E7DC35CB4Q43168913-5437A8D7-C1F9-4C88-93CA-F5CA8F7897DBQ44341506-702A41BA-E17B-4BE2-A9B7-F8FDA156ED08Q44526578-5C30171D-3853-4F20-A233-B9141852E2CCQ46247986-A540D471-5350-4558-92C3-E64A37597174Q47194075-D8358C97-317B-4A8A-9B40-F6918E15BF2DQ47229887-C5D1A0F1-9AA2-4332-87AD-8AD42E71E058Q47604044-69896C30-99BB-457C-BBD4-82D379EE3BC6Q50089693-DC130E1A-7B02-4E00-9119-23DA0AE31242
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunological perspectives of leishmaniasis.
@en
Immunological perspectives of leishmaniasis.
@nl
type
label
Immunological perspectives of leishmaniasis.
@en
Immunological perspectives of leishmaniasis.
@nl
prefLabel
Immunological perspectives of leishmaniasis.
@en
Immunological perspectives of leishmaniasis.
@nl
P2860
P356
P1476
Immunological perspectives of leishmaniasis.
@en
P2093
Shalini Gautam
P2860
P304
P356
10.4103/0974-777X.62876
P407
P577
2010-05-01T00:00:00Z